The brain-penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury

Zubair Ahmed; Richard Tuxworth

doi:10.1002/ctm2.962

The brain-penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury

Research output: Contribution to journal › Letter › peer-review

107 Downloads (Pure)

Original language	English
Article number	e962
Number of pages	6
Journal	Clinical and Translational Medicine
Volume	12
Issue number	7
DOIs	https://doi.org/10.1002/ctm2.962
Publication status	Published - 12 Jul 2022

Keywords

Ataxia Telangiectasia Mutated Proteins
Axons
Brain
Humans
Nerve Regeneration
Recovery of Function
Spinal Cord Injuries/drug therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ctm2.962Licence: Creative Commons: Attribution (CC BY)

AhmedZ2022brainFinal published version, 3.12 MBLicence: Creative Commons: Attribution (CC BY)

Cite this

@article{c7101f0879514f5bba9ab87e2a040575,

title = "The brain-penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury",

keywords = "Ataxia Telangiectasia Mutated Proteins, Axons, Brain, Humans, Nerve Regeneration, Recovery of Function, Spinal Cord Injuries/drug therapy",

author = "Zubair Ahmed and Richard Tuxworth",

year = "2022",

month = jul,

day = "12",

doi = "10.1002/ctm2.962",

language = "English",

volume = "12",

journal = "Clinical and Translational Medicine",

issn = "2001-1326",

publisher = "Wiley",

number = "7",

}

TY - JOUR

T1 - The brain-penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury

AU - Ahmed, Zubair

AU - Tuxworth, Richard

PY - 2022/7/12

Y1 - 2022/7/12

KW - Ataxia Telangiectasia Mutated Proteins

KW - Axons

KW - Brain

KW - Humans

KW - Nerve Regeneration

KW - Recovery of Function

KW - Spinal Cord Injuries/drug therapy

U2 - 10.1002/ctm2.962

DO - 10.1002/ctm2.962

M3 - Letter

C2 - 35818848

SN - 2001-1326

VL - 12

JO - Clinical and Translational Medicine

JF - Clinical and Translational Medicine

IS - 7

M1 - e962

ER -

The brain-penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this